An iGlu receptor antagonist and its simultaneous use with an anticancer drug for cancer therapy

Chemistry : a European Journal
Si Yu TanYanli Zhao

Abstract

Glutamate receptor antagonists have been known to play a crucial role in the treatment of many neuronal diseases. Recently, these antagonists have also shown therapeutic effects in the treatment of cancer. In this study, an ionotropic glutamate (iGlu) receptor antagonist, 4-hydroxyphenylacetyl spermine (L1), was used concurrently with a common anticancer drug, doxorubicin (Dox), for simultaneous cancer therapy. Mesoporous silica nanoparticles (MSNPs) were employed as the delivery vehicle for both L1 and Dox by conjugating the iGlu receptor antagonist on the surface and encapsulating Dox within the mesopores. Dox was then trapped within the mesopores by functionalizing a redox-cleavable capping group on the MSNP surface, and it could be released upon exposure to the reductive glutathione. In vitro studies on B16F10 and NIH3T3 cell lines revealed that the iGlu receptor antagonist L1 exhibited therapeutic as well as targeting effects. In addition, the simultaneous use of therapeutic L1 and Dox proved to be synergistic in the treatment of cancer. The present work demonstrated the feasibility of employing a delivery system to deliver both neuroprotective drug and anticancer drug for efficient anticancer treatment.

References

Jul 1, 1997·Neuroscience and Biobehavioral Reviews·W DanyszG Quack
May 2, 2001·Proceedings of the National Academy of Sciences of the United States of America·W RzeskiC Ikonomidou
May 24, 2001·Proceedings of the National Academy of Sciences of the United States of America·E A Cavalheiro, J W Olney
Sep 5, 2001·Nature Medicine·T TakanoM Nedergaard
Oct 31, 2002·Nature Neuroscience·John A Kemp, Ruth M McKernan
Jun 30, 2004·Medicinal Research Reviews·Kristian Strømgaard, Ian Mellor
Oct 19, 2005·Proceedings of the National Academy of Sciences of the United States of America·Andrzej StepulakChrysanthy Ikonomidou
Jan 21, 2006·Nature Reviews. Drug Discovery·Stuart A Lipton
Aug 8, 2006·Medicinal Research Reviews·Daniela CatarziFlavia Varano
Sep 1, 2006·Journal of Medicinal Chemistry·Trine F AndersenKristian Strømgaard
Oct 31, 2006·Medical Hypotheses·Ba X HoangStephen A Levine
Jan 24, 2007·Nature Reviews. Neuroscience·Victor A DerkachThomas R Soderling
Apr 3, 2007·Pharmacology & Therapeutics·Márcia Renata MortariWagner Ferreira dos Santos
Jun 26, 2007·Journal of the American Chemical Society·Igor I SlowingVictor S-Y Lin
Aug 21, 2007·Neurochemistry International·Gábor SzénásiLaszlo G Harsing
May 10, 2008·Nature Reviews. Neuroscience·Paulo S Pinheiro, Christophe Mulle
Jun 28, 2008·Pigment Cell & Melanoma Research·Hwa Jin LeeSuzie Chen
Jun 16, 2009·Histochemistry and Cell Biology·Andrzej StepulakChrysanthy Ikonomidou
Apr 30, 2010·Journal of Combinatorial Chemistry·Ting MaYongping Yu
May 11, 2010·Journal of Controlled Release : Official Journal of the Controlled Release Society·Yanzhuo ZhangSiling Wang
Aug 7, 2010·Small·Juan L Vivero-EscotoVictor S-Y Lin
Aug 31, 2010·Journal of the American Chemical Society·Yan-Li ZhaoJeffrey I Zink
Jun 17, 2011·Accounts of Chemical Research·Michael W AmbrogioJ Fraser Stoddart
Aug 30, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·Stefanie WohlfartJörg Kreuter
Jan 5, 2012·Chemical Society Reviews·Zongxi LiJeffrey I Zink
Apr 20, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Antonio NunesKostas Kostarelos
Jan 12, 2013·Journal of Controlled Release : Official Journal of the Controlled Release Society·Wei ChenZhiyuan Zhong
Mar 23, 2013·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ellen C DenglerErin D Milligan
May 21, 2013·Nature Reviews. Neuroscience·Pierre PaolettiQiang Zhou
Feb 14, 2014·Scientific Reports·Michael E HildebrandMichael W Salter
Mar 13, 2014·Journal of Neural Transmission·Andrzej StepulakChrysanthy Ikonomidou
Jul 19, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Beilu ZhangKaiyong Cai

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.